In Vitro activities of dermaseptins K4S4and K 4K20S4 against Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa planktonic growth and biofilm formation

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 4, 2014, Pages 2221-2228

  Zaïri, Amira ^a   Ferrières, Lionel ^b   Latour Lambert, Patricia ^b   Beloin, Christophe ^b   Tangy, Frédéric ^b   Ghigo, Jean Marc ^b   Hani, Khaled ^a  

^a UNIVERSITY OF SOUSSE   (Tunisia)

^b INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DERMASEPTIN; DERMASEPTIN K4 K20 S4; DERMASEPTIN K4 S4; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BIOFILM; CARBON SOURCE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY ASSAY; DRUG CYTOTOXICITY; ESCHERICHIA COLI; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

AMPHIBIAN PROTEINS; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BIOFILMS; ESCHERICHIA COLI; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HELA CELLS; HUMANS; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

EID: 84896975604     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02142-13     Document Type: Article

References (45)

1. Donlan RM, Costerton JW. 2002. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 15:167-193. http://dx.doi.org/10.1128/CMR.15.2.167-193.2002. (Pubitemid 34303762)
2. Yala JF, Thebault P, Héquet A, Humblot V, Pradier CM, Berjeaud JM. 2011. Elaboration of antibiofilm materials by chemical grafting of an antimicrobial peptide. Appl. Microbiol. Biotechnol. 89:623-634. http://dx.doi.org/10.1007/s00253-010-2930-7.
3. Dongari-Bagtzoglou A. 2008. Mucosal biofilms: challenges and future directions. Expert Rev. Anti Infect. Ther. 6:141-144. http://dx.doi.org/10.1586/ 14787210.6.2.141.
4. Francolini I, Donelli G. 2010. Prevention and control of biofilm-based medical device-related infections. FEMS Immunol. Med. Microbiol. 59:227-238. http://dx.doi.org/10.1111/j.1574-695X.2010.00665.x.
5. Belley A, Neesham-Grenon E, McKay G, Arhin FF, Harris R, Beveridge T, Parr TR, Jr, Moeck G. 2009. Oritavancin kills stationary-phase and biofilm Staphylococcus aureus cells in vitro. Antimicrob. Agents Chemother. 53:918-925. http://dx.doi.org/10.1128/AAC.00766-08.
6. Schillaci D, Arizza V, Parrinello N, Di Stefano V, Fanara S, Muccilli V, Cunsolo V, Haagensen JJ, Molin S. 2010. Antimicrobial and antistaphylococcal biofilm activity from the sea urchin Paracentrotus lividus. J. Appl. Microbiol. 108: 17-24. http://dx.doi.org/10.1111/j.1365-2672.2009.04394.x.
7. Salay LC, Nobre TM, Colhone MC, Zaniquelli ME, Ciancaglini P, Stabeli RG, Leite JR, Zucolotto V. 2011. Dermaseptin 01 as antimicrobial peptide with rich biotechnological potential: study of peptide interaction with membranes containing Leishmania amazonensis lipid-rich extract and membrane models. J. Pept. Sci. 17:700-707. http://dx.doi.org/10.1002/psc.1392.
8. Zampa MF, de S Araújo IM, dos Santos JR, Jr, Zucolotto V, de SA Leite JR, Eiras C. 2012. Development of a novel biosensor using cationic antimicrobial peptide and nickel phthalocyanine ultrathin films for electrochemical detection of dopamine. Int. J. Anal. Chem. 2012:850969. http://dx.doi.org/10.1155/2012/850969.
9. Krauson AJ, He J, Wimley WC. 2012. Determining the mechanism of membrane permeabilizing peptides: identification of potent, equilibrium pore-formers. Biochim. Biophys. Acta 1818:1625-1632. http://dx.doi.org/10.1016/j.bbamem.2012. 02.009.
10. Nicolas P, El Amri C. 2009. The dermaseptin superfamily: a gene-based combinatorial library of antimicrobial peptides. Biochim. Biophys. Acta 1788:1537-1550. http://dx.doi.org/10.1016/j.bbamem.2008.09.006.
11. Rivas L, Luque-Ortega JR, Andreu D. 2009. Amphibian antimicrobial peptides and protozoa: lessons from parasites. Biochim. Biophys. Acta 1788:1570-1581. http://dx.doi.org/10.1016/j.bbamem.2008.11.002.
12. Zasloff M. 2002. Antimicrobial peptides of multicellular organisms. Nature 415:389-395. http://dx.doi.org/10.1038/415389a. (Pubitemid 34100944)
13. Mor A, Nguyen VH, Delfour A, Migliore-Samour D, Nicolas P. 1991. Isolation, amino acid sequence and synthesis of dermaseptin, a novel antimicrobial peptide of amphibian skin. Biochemistry 30:8824-8830. http://dx.doi.org/10.1021/bi00100a014.
14. Mor A, Rouffaud MA, Montagne JJ, Nguyen VH, Nicolas P. 1993. Natural and synthetic dermaseptins: in vitro large spectrum antimicrobial peptides. J. Mycol. Med. 3:137-143.
15. Lequin O, Ladram A, Chabbert L, Bruston F, Convert O, Vanhoye D, Chassaing G, Nicolas P, Amiche M. 2006. Dermaseptin S9, an alphahelical antimicrobial peptide with a hydrophobic core and cationic termini. Biochemistry 45:468-480. http://dx.doi.org/10.1021/bi051711i. (Pubitemid 43100413)
16. 4: a potential candidate for development of a new microbicide contraceptive agent: an in vitro study. Eur. J. Contracept. Reprod. Health Care 18:79-87. http://dx.doi.org/10.3109/13625187.2013.769950.
17. Marynka K, Rotem S, Portnaya I, Cogan U, Mor A. 2007. In vitro discriminative antipseudomonal properties resulting from acyl substitution of N-terminal sequence of dermaseptin S4 derivatives. Chem. Biol. 14:75-85. http://dx.doi.org/10.1016/j.chembiol.2006.11.009. (Pubitemid 46127846)
18. Zairi A, Tangy F, Ducos-Galand M, Alonso JM, Hani K. 2007. Susceptibility of Neisseria gonorrhoeae to antimicrobial peptides from amphibian skin, dermaseptin, and derivatives. Diagn. Microbiol. Infect. Dis. 57:319-324. http://dx.doi.org/10.1016/j.diagmicrobio.2006.11.006. (Pubitemid 46330659)
19. Porat Y, Marynka K, Tam A, Steinberg D, Mor A. 2006. Acyl-substituted dermaseptin S4 derivatives with improved bactericidal properties, including on oral microflora. Antimicrob. Agents Chemother. 50:4153-4160. http://dx.doi.org/10.1128/AAC.00750-06. (Pubitemid 44865160)
20. Dagan A, Efron L, Gaidukov L, Mor A, Ginsburg H. 2002. In vitro antiplasmodium effects of dermaseptins. Antimicrob. Agents Chemother. 46:1059-1066. http://dx.doi.org/10.1128/AAC.46.4.1059-1066.2002.
21. Efron L, Dagan A, Gaidukov L, Ginsburg H, Mor A. 2002. Direct interaction of dermaseptin S4 aminoheptanoyl derivative with intraerythrocytic malaria parasite leading to increased specific antiparasitic activity in culture. J. Biol. Chem. 277:24067-24072. http://dx.doi.org/10.1074/jbc.M202089200. (Pubitemid 34951919)
22. Salay LC, Nobre TM, Colhone MC, Zaniquelli ME, Ciancaglini P, Stabeli RG, Leite JR, Zucolotto V. 2011. Dermaseptin S1 as antimicrobial peptide with rich biotechnological potential: study of peptide interaction with membranes containing Leishmania amazonensis lipid-rich extract and membrane models. J. Pept. Sci. 17:700-707. http://dx.doi.org/10.1002/psc.1392.
23. Pérez-Cordero JJ, Lozano JM, Cortés J, Delgado G. 2011. Leishmanicidal activity of synthetic antimicrobial peptides in an infection model with human dendritic cells. Peptides 32:683-690. http://dx.doi.org/10. 1016/j.peptides.2011.01.011.
24. Morton CO, Dos Santos SC, Coote P. 2007. An amphibian-derived, cationic, alpha-helical antimicrobial peptide kills yeast by caspase-independent but AIF-dependent programmed cell death. Mol. Microbiol. 65:494-507. http://dx.doi.org/10.1111/j.1365-2958.2007.05801.x. (Pubitemid 47052730)
25. Bergaoui I, Zairi A, Tangy F, Aouni M, Selmi B, Hani K. 2013. In vitro antiviral activity of dermaseptin S4 and derivatives from amphibian skin against herpes simplex virus type 2. J. Med. Virol. 85:272-281. http://dx.doi.org/10. 1002/jmv.23450.
26. Lorin C, Saidi H, Belaid A, Zairi A, Baleux F, Hocini H, Bélec L, Hani K, Tangy F. 2005. The antimicrobial peptide dermaseptin S4 inhibits HIV-1 infectivity in vitro. Virology 334:264-275. http://dx.doi.org/10.1016/j.virol. 2005.02.002. (Pubitemid 40386960)
27. Belaid A, Aouni M, Khelifa R, Trabelsi A, Jemmali M, Hani K. 2002. In vitro antiviral activity of dermaseptins against herpes simplex virus type 1. J. Med. Virol. 66:229-234. http://dx.doi.org/10.1002/jmv.2134. (Pubitemid 34020073)
28. Amiche M, Galanth C. 2011. Dermaseptins as models for the elucidation of membrane-acting helical amphipathic antimicrobial peptides. Curr. Pharm. Biotechnol. 12: 1184-1193. http://dx.doi.org/10.2174/138920111796117319.
29. Wimley WC. 2010. Describing the mechanism of antimicrobial peptide action with the interfacial activity model. ACS Chem. Biol. 5:905-917. http://dx.doi.org/10.1021/cb1001558.
30. Navon-Venezia SN, Feder R, Gaidukov L, Carmeli Y, Mor A. 2002. Antimicrobial properties of dermaseptin S4 derivatives with in vivo activity. Antimicrob. Agents Chemother. 46:689-694. http://dx.doi.org/10.1128/AAC.46.3. 689-694.2002. (Pubitemid 34157652)
31. Kustanovich I, Shallev DE, Mikhlin M, Gaidukov L, Mor A. 2002. Structural requirements for potent versus selective cytotoxicity for antimicrobial dermaseptin S4 derivates. J. Biol. Chem. 277:16941-16951. http://dx.doi.org/10. 1074/jbc.M111071200. (Pubitemid 34967722)
32. Efron L, Dagan A, Gaidukov L, Ginsburg H, Mor A. 2002. Direct interaction of dermaseptin S4 aminoheptanoyl derivate with intraerythrocytic malaria parasite leading to increased specific antiparasitic activity in culture. J. Biol. Chem. 277:24067-24072. http://dx.doi.org/10.1074/jbc.M202089200. (Pubitemid 34951919)
33. Moller S, Sternberg C, Andersen JB, Christensen Ramos BB, Givskov M, Molin S. 1998. In situ gene expression in mixed-culture biofilms: evidence of metabolic interactions between community members. Appl. Environ. Microbiol. 64:721-732. (Pubitemid 28079847)
34. SAS Institute. 2000. SAS/STAT, user's guide, release 6.12. SAS Institute, Cary, NC.
35. Amer LS, Bishop BM, van Hoek ML. 2010. Antimicrobial and antibiofilm activity of cathelicidins and short, synthetic peptides against Francisella. Biochem. Biophys. Res. Commun. 396:246-251. http://dx.doi.org/10.1016/j.bbrc. 2010.04.073.
36. Kanthawong S, Bolscher JG, Veerman EC, Van Marle J, De Soet HJ, Nazmi K, Wongratanacheewin S, Taweechaisupapong S. 2012. Antimicrobial and antibiofilm activity of LL-37 and its truncated variants against Burkholderia pseudomallei. Int. J. Antimicrob. Agents 39:39-44. http://dx.doi.org/10.1016/j.ijantimicag. 2011.09.010.
37. Wei GX, Campagna AN, Bobek LA. 2006. Effect of MUC7 peptides on the growth of bacteria and on Streptococcus mutans biofilm. J. Antimicrob. Chemother. 57:1100-1109. http://dx.doi.org/10.1093/jac/dkl120. (Pubitemid 44644411)
38. da Silva BR, De Freitas VA, Nascimento-Neto LG, Carneiro VA, Arruda FV, De Aguiar AS, Cavada BS, Teixeira EH. 2012. Antimicrobial peptide control of pathogenic microorganisms of the oral cavity: a review of the literature. Peptides 36:315-321. http://dx.doi.org/10.1016/j.peptides.2012.05.015.
39. Beckloff N, Laube D, Castro T, Furgang D, Park S, Perlin D, Clements D, Tang H, Scott RW, Tew GN, Diamond G. 2007. Activity of an antimicrobial peptide mimetic against planktonic and biofilm cultures of oral pathogens. Antimicrob. Agents Chemother. 51:4125-4132. http://dx.doi.org/10.1128/AAC.00208-07. (Pubitemid 350057814)
40. Neiva M, Vargas DC, Conceição K, Rádis-Baptista G, Assakura MT, Jared C, Hayashi MA. 2013. Gene expression analysis by ESTs sequencing of the Brazilian frog Phyllomedusa nordestina skin glands. Toxicon 61:139-150. http://dx.doi.org/10.1016/j.toxicon.2012.10.016.
41. Choi H, Lee DG. 2012. Antimicrobial peptide pleurocidin synergizes with antibiotics through hydroxyl radical formation and membrane damage, and exerts antibiofilm activity. Biochim. Biophys. Acta 1820:1831-1838. http://dx.doi.org/10.1016/j.bbagen.2012.08.012.
42. Dashper SG, Pan Y, Veith PD, Chen YY, Toh EC, Liu SW, Cross KJ, Reynolds EC. 2012. Lactoferrin inhibits Porphyromonas gingivalis proteinases and has sustained biofilm inhibitory activity. Antimicrob. Agents Chemother. 56:1548-1556. http://dx.doi.org/10.1128/AAC.05100-11.
43. Zhang R, Zhou M, Wang L, McGrath S, Chen T, Chen X, Shaw C. 2010. Phylloseptin-1 (PSN-1) from Phyllomedusa sauvagei skin secretion: a novel broad-spectrum antimicrobial peptide with antibiofilm activity. Mol. Immunol. 47:2030-2037. http://dx.doi.org/10.1016/j.molimm.2010.04.010.
44. Mah TF, O'Toole GA. 2001. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol. 9:34-39. http://dx.doi.org/10.1016/ S0966-842X(00)01913-2.
45. B is essential for biofilm development by Staphylococcus aureus. Mol. Microbiol. 48:1075-1087. http://dx.doi.org/10.1046/j.1365-2958.2003.03493.x.